Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae
- 1 May 1996
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 25 (1), 43-45
- https://doi.org/10.1016/0732-8893(96)00068-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The Prevalence of Drug-ResistantStreptococcus pneumoniaeIn AtlantaNew England Journal of Medicine, 1995
- Emergence of drug-resistant pneumococcal infections in the United StatesPublished by American Medical Association (AMA) ,1994
- Induction of Resistance of Streptococcus pneumoniae to Quinolones in vitroChemotherapy, 1993
- Pneumococcal bacteremia in Monroe County, New York.American Journal of Public Health, 1992
- In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1992
- New and Emerging Etiologies for Community-Acquired Pneumonia with Implications for TherapyMedicine, 1990
- Pneumococcal bacteremia in Charleston County, South Carolina. A decade laterArchives of Internal Medicine, 1990
- Pneumococcal resistance to antibioticsClinical Microbiology Reviews, 1990
- World-wide development of antibiotic resistance in pneumococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Epidemiology of Clinically Significant Isolates of Streptococcus pneumoniae in the United StatesClinical Infectious Diseases, 1981